Literature DB >> 24448245

Universal marker and detection tool for human sarcoma circulating tumor cells.

Arun Satelli1, Abhisek Mitra, Jeffry J Cutrera, Marcos Devarie, Xueqing Xia, Davis R Ingram, Denada Dibra, Neeta Somaiah, Keila E Torres, Vinod Ravi, Joseph A Ludwig, Eugenie S Kleinerman, Shulin Li.   

Abstract

To date, no specific marker exists for the detection of circulating tumor cells (CTC) from different types of sarcomas, though tools are available for detection of CTCs in peripheral blood of patients with cancer for epithelial cancers. Here, we report cell-surface vimentin (CSV) as an exclusive marker on sarcoma CTC regardless of the tissue origin of the sarcoma as detected by a novel monoclonal antibody. Utilizing CSV as a probe, we isolated and enumerated sarcoma CTCs with high sensitivity and specificity from the blood of patients bearing different types of sarcoma, validating their phenotype by single cell genomic amplification, mutation detection, and FISH. Our results establish the first universal and specific CTC marker described for enumerating CTCs from different types of sarcoma, thereby providing a key prognosis tool to monitor cancer metastasis and relapse. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24448245      PMCID: PMC3959622          DOI: 10.1158/0008-5472.CAN-13-1739

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Dissecting the metastatic cascade.

Authors:  Klaus Pantel; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

2.  SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells.

Authors:  Delphine Huet; Martine Bagot; Denis Loyaux; Joël Capdevielle; Laurence Conraux; Pascual Ferrara; Armand Bensussan; Anne Marie-Cardine
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 3.  Focus on sarcomas.

Authors:  Crystal L Mackall; Paul S Meltzer; Lee J Helman
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

4.  Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells.

Authors:  Nicole F Steinmetz; Choi-Fong Cho; Amber Ablack; John D Lewis; Marianne Manchester
Journal:  Nanomedicine (Lond)       Date:  2011-02       Impact factor: 5.307

5.  Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy.

Authors:  Jeffry Cutrera; Denada Dibra; Xueqing Xia; Azeem Hasan; Scott Reed; Shulin Li
Journal:  Mol Ther       Date:  2011-03-08       Impact factor: 11.454

Review 6.  Circulating tumor cells: from bench to bedside.

Authors:  Marija Balic; Anthony Williams; Henry Lin; Ram Datar; Richard J Cote
Journal:  Annu Rev Med       Date:  2012-10-18       Impact factor: 13.739

7.  Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors.

Authors:  R Yokoyama; R Schneider-Stock; K Radig; T Wex; A Roessner
Journal:  Pathol Res Pract       Date:  1998       Impact factor: 3.250

8.  Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.

Authors:  Steven G Dubois; C Lorrie Epling; Juli Teague; Katherine K Matthay; Elizabeth Sinclair
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

9.  MDM2 gene amplification in metastatic osteosarcoma.

Authors:  M Ladanyi; C Cha; R Lewis; S C Jhanwar; A G Huvos; J H Healey
Journal:  Cancer Res       Date:  1993-01-01       Impact factor: 12.701

10.  MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.

Authors:  C Zietz; M Rössle; C Haas; A Sendelhofert; A Hirschmann; M Stürzl; U Löhrs
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more
  65 in total

1.  Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody.

Authors:  David Frescas; Christelle M Roux; Semra Aygun-Sunar; Anatoli S Gleiberman; Peter Krasnov; Oleg V Kurnasov; Evguenia Strom; Lauren P Virtuoso; Michelle Wrobel; Andrei L Osterman; Marina P Antoch; Vadim Mett; Olga B Chernova; Andrei V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

2.  PD-L1 Detection on Circulating Melanoma Cells.

Authors:  Joseph W Po; Yafeng Ma; Bavanthi Balakrishnar; Daniel Brungs; Farhad Azimi; Adam Cooper; Erin Saricilar; Vinay Murthy; Paul de Souza; Therese M Becker
Journal:  Methods Mol Biol       Date:  2021

3.  ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells.

Authors:  Weiran Gao; Xifan Mei; Jikun Wang; Xianglin Zhang; Yajiang Yuan
Journal:  Tumour Biol       Date:  2015-04-20

4.  MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes.

Authors:  Mohit Sachdeva; Jeffrey K Mito; Chang-Lung Lee; Minsi Zhang; Zhizhong Li; Rebecca D Dodd; David Cason; Lixia Luo; Yan Ma; David Van Mater; Rebecca Gladdy; Dina C Lev; Diana M Cardona; David G Kirsch
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

Review 5.  CTC analysis: an update on technological progress.

Authors:  Izhar S Batth; Abhisek Mitra; Sierra Rood; Scott Kopetz; David Menter; Shulin Li
Journal:  Transl Res       Date:  2019-07-11       Impact factor: 7.012

6.  Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.

Authors:  Arun Satelli; Zachary Brownlee; Abhisek Mitra; Qing H Meng; Shulin Li
Journal:  Clin Chem       Date:  2014-10-21       Impact factor: 8.327

Review 7.  Using circulating tumor cells to inform on prostate cancer biology and clinical utility.

Authors:  Jing Li; Simon G Gregory; Mariano A Garcia-Blanco; Andrew J Armstrong
Journal:  Crit Rev Clin Lab Sci       Date:  2015-06-16       Impact factor: 6.250

8.  Cell-surface vimentin-positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumors.

Authors:  Heming Li; Qing H Meng; Hyangsoon Noh; Neeta Somaiah; Keila E Torres; Xueqing Xia; Izhar S Batth; Cissimol P Joseph; Mengyuan Liu; Ruoyu Wang; Shulin Li
Journal:  Oncoimmunology       Date:  2018-01-08       Impact factor: 8.110

Review 9.  Circulating tumor cells in sarcomas: a brief review.

Authors:  Le Chang; Greg Asatrian; Sarah M Dry; Aaron W James
Journal:  Med Oncol       Date:  2014-12-10       Impact factor: 3.064

Review 10.  Biology and clinical significance of circulating tumor cell subpopulations in lung cancer.

Authors:  Linda O'Flaherty; Harriet Wikman; Klaus Pantel
Journal:  Transl Lung Cancer Res       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.